Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Azelastine hydrochloride
Cat. No.:
OB0225LY-0127
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and LC-MS.
Size:
Product Overview
Description:
Azelastine hydrochloride is a topical antihistamine with antihistaminergic activity.
Synonym:
Optivar; Azelastine HCl; Allergodil; Astelin; 79307-93-0; 4-(4-Chlorobenzyl)-2-(1-methylazepan-4-yl)phthalazin-1(2H)-one hydrochloride; 1(2H)-Phthalazinone, 4-((4-chlorophenyl)methyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-, monohydrochloride
CAS No.:
79307-93-0
Compound CID:
54360
Formula:
C22H24ClN3O·HCl
Formula Weight:
418.36
Specification
Relative Density:
1.25 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Azelastine hydrochloride can be used in the study of allergic rhinitis for fast relief of symptoms such as nasal congestion, runny nose and sneezing.
Library Information
Targets:
Histamine receptor; SARS-CoV
Receptors:
H1 receptor
Pathways:
Microbiology/Virology; Neuronal signaling; GPCR/G protein; Immunology/Inflammation
Plate Number:
AOCL-2
Plate Location:
e10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
84 mg/mL; 200.78 mM
Water Max Solubility:
35 mg/mL; 83.66 mM
Ethanol Max Solubility:
57 mg/mL; 136.2 mM
